Reported Tuberculosis in the United States, 2018
State & Local Data
Reporting areas include 50 states, 2 cities (NYC and DC), 5 U.S. territories, and 3 independent countries that are in compacts of free association with the United States.
Among U.S. states, the majority of TB cases continue to be reported from four states: California (23.2%), Texas (12.5%), New York (8.3%), and Florida (6.5%). However, considering incidence rates by reporting area, Alaska (8.5 cases per 100,000 persons) has the highest TB rate, followed by Hawaii (8.4), New York City (6.7), California (5.3), the District of Columbia (5.1), and Texas (3.9).
- TB by Age Group: Reporting Areas, 2018
- TB by Hispanic Ethnicity and Race: Reporting Areas, 2018
- TB U.S.-Born and Non-U.S.–Born Persons: United States and the District of Columbia, 2018
- TB Among Non-U.S.–Born Persons, by Number of Years in the U.S.: United States and the District of Columbia, 2018
- TB by Age Group: Metropolitan Statistical Areas with ≥500,000 Population, 2018
- TB by Race/Ethnicity: Metropolitan Statistical Areas with ≥500,000 Population, 2018
- TB by Origin of Birth: Metropolitan Statistical Areas with ≥500,000 Population, 2018
- TB Risk Factors: Reporting Areas, 2018
- TB in Correctional Facilities, Ages ≥15 Years: Reporting Areas, 2018
- TB in Persons Experiencing Homelessness, Ages ≥15 Years: Reporting Areas, 2018
- TB in Long–Term Care Facilities, Ages ≥15 Years: Reporting Areas, 2018
- TB Among Injecting Drug Users, Ages ≥15 Years: Reporting Areas, 2018
- TB Non-injecting Drug Users, Ages ≥15 Years: Reporting Areas, 2018
- TB Among Excess Alcohol Users, Ages ≥15 Years: Reporting Areas, 2018
- TB by Primary Occupation, Ages ≥15 Years: Reporting Areas, 2018
- TB by HIV Status: Reporting Areas, 2018
- TB by Initial Drug Regimen: Reporting Areas, 2018
- Directly Observed Therapy (DOT): Reporting Areas, 2016
- Reason TB Therapy Was Stopped: Reporting Areas, 2016
- Reason TB Therapy Was Extended: Reporting Areas, 2016
- Completion of TB Therapy (COT): Reporting Areas, 2016
- Persons Completing Therapy for Whom Therapy Was Indicated for ≤1 Year: Reporting Areas, 2012–2016
